Ethical implications of poor comparative effectiveness evidence: obligations in industry-research partnerships

Affiliations

¹ Department of Psychiatry, University of Oxford, Oxford OX3 7JX, UK; Wellcome Centre for Ethics and Humanities, Big Data Institute, University of Oxford, Oxford, UK. Electronic address: ilina.singh@psych.ox.ac.uk.
² Department of Health Policy, London School of Economics and Political Science, London, UK.
³ Yale School of Medicine, Yale University, New Haven, CT, USA.
⁴ Division of Medical Ethics, New York University, Grossman School of Medicine New York, NY, USA.
⁵ Department of Psychiatry, University of Oxford, Oxford OX3 7JX, UK; Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford, UK.

Comment

Ilina Singh et al. Lancet. 2020.

. 2020 Mar 21;395(10228):926-928.

doi: 10.1016/S0140-6736(20)30413-X.

¹ Department of Psychiatry, University of Oxford, Oxford OX3 7JX, UK; Wellcome Centre for Ethics and Humanities, Big Data Institute, University of Oxford, Oxford, UK. Electronic address: ilina.singh@psych.ox.ac.uk.
² Department of Health Policy, London School of Economics and Political Science, London, UK.
³ Yale School of Medicine, Yale University, New Haven, CT, USA.
⁴ Division of Medical Ethics, New York University, Grossman School of Medicine New York, NY, USA.
⁵ Department of Psychiatry, University of Oxford, Oxford OX3 7JX, UK; Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford, UK.

No abstract available

Comment on

Generating comparative evidence on new drugs and devices before approval.
Naci H, Salcher-Konrad M, Kesselheim AS, Wieseler B, Rochaix L, Redberg RF, Salanti G, Jackson E, Garner S, Stroup TS, Cipriani A. Naci H, et al. Lancet. 2020 Mar 21;395(10228):986-997. doi: 10.1016/S0140-6736(19)33178-2. Lancet. 2020. PMID: 32199486 Review.
Generating comparative evidence on new drugs and devices after approval.
Cipriani A, Ioannidis JPA, Rothwell PM, Glasziou P, Li T, Hernandez AF, Tomlinson A, Simes J, Naci H. Cipriani A, et al. Lancet. 2020 Mar 21;395(10228):998-1010. doi: 10.1016/S0140-6736(19)33177-0. Lancet. 2020. PMID: 32199487 Review.